AHA Urges Lilly to ‘Abandon’ 340B In-House Claims Data Policy, Work with Hospitals on Neutral Claims Clearinghouse
A major hospital group on Wednesday asked Indiana-based drugmaker Eli Lilly to end its new 340B in-house pharmacy claims data [...]

